United States · Bill · HR
H.R. 33 (103rd)
Drug Testing Quality Act
Introduced
5 January 1993
Last action
—
Status
Referred to the Subcommittee on Health and the Environment.
Sponsors
—
Subjects
Discovery layer
Source updated
3 June 2026
Summary
Drug Testing Quality Act - Amends the Public Health Service Act to establish a program for the certification of laboratories for the performance of toxicological urinalysis for drug testing programs. Requires the program to conform to specified mandatory guidelines. Mandates regulations to ensure the integrity of drug testing programs. Sets forth specimen collection procedures. Prohibits: (1) performing urinalysis for drug testing without certification; and (2) subject to exception, testing for a drug or drug class not listed in certain provisions. Provides for criminal penalties, administrative remedies, injunctions, and certain civil actions. Requires fees for certification and recertification to cover costs.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 5 January 1993
Introduced in House (PDF)
Introduced in House · EN · 5 January 1993
Introduced in House
summary · EN · 5 January 1993
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/103rd-congress/house-bill/33
- Open data entity: https://api.congress.gov/v3/bill/103/hr/33